Hypertension: Understanding the Silent Killer and its Impact on Health

Chong Maffoni^*
*Correspondence: Chong Maffoni, Departamento de Medicina Preventiva y Salud Pública, Universidad de Granada, 18012 Granada, Spain, Email:

Introduction

Improving therapy adherence is a critical issue in healthcare, impacting patient outcomes, quality of life and healthcare costs. Therapy adherence, also known as medication adherence or compliance, refers to the degree to which a patient follows the prescribed treatment regimen, including taking medications as directed, attending follow-up appointments and adhering to other medical advice. Non-adherence to treatment is a common problem in healthcare systems worldwide, contributing to poor clinical outcomes, increased morbidity and mortality and a significant economic burden on healthcare systems. The issue of therapy adherence is particularly crucial in chronic conditions such as diabetes, hypertension, asthma, cardiovascular disease and cancer, where ongoing treatment is essential for managing symptoms, preventing complications and improving long-term health outcomes [1]. Hypertension, commonly referred to as high blood pressure, is a widespread health condition that affects millions worldwide. Often called the "silent killer," it typically develops without noticeable symptoms, silently damaging the body over time. Left unmanaged, hypertension can lead to severe health complications, including heart disease, stroke, kidney failure, and other life-threatening conditions. This article aims to shed light on the causes, symptoms, risk factors, and preventive measures associated with hypertension. By understanding the underlying mechanisms and adopting lifestyle changes, individuals can significantly reduce their risk and lead healthier lives.

Description

Hypertension occurs when the force of blood against the walls of the arteries remains consistently elevated, placing undue stress on the cardiovascular system. Normal blood pressure is typically measured as less than 120/80 mmHg, while readings of 140/90 mmHg or higher are considered hypertensive. There are two primary types of hypertension: primary (essential) hypertension, which develops over time without an identifiable cause, and secondary hypertension, which is often a result of underlying conditions like kidney disease or hormonal imbalances. The risk factors for hypertension include genetic predisposition, obesity, sedentary lifestyle, excessive salt intake, stress, smoking, and excessive alcohol consumption. Age, gender, and ethnicity can also play a role in susceptibility. While hypertension is a serious condition, it is also highly preventable and manageable. Lifestyle interventions, such as maintaining a balanced diet rich in fruits and vegetables, engaging in regular physical activity, limiting alcohol and sodium intake, and managing stress, are vital steps in controlling blood pressure. In some cases, medication may also be prescribed to keep blood pressure within a healthy range.

By raising awareness and encouraging proactive measures, we can combat hypertension and reduce its burden on individuals and healthcare systems worldwide. Therapy adherence has been recognized as one of the most significant factors influencing the success of medical treatments. When patients fail to adhere to prescribed therapies, they are more likely to experience disease progression, exacerbations of symptoms and the need for additional treatments or hospitalizations. In contrast, good adherence to therapy leads to better clinical outcomes, improved quality of life and reduced healthcare utilization. Therefore, understanding the factors that influence therapy adherence, as well as developing strategies to improve adherence, is essential for enhancing patient care and optimizing healthcare delivery.

The effects of therapy adherence on patient quality of life are profound. For many patients, the primary goal of treatment is to improve their quality of life by reducing symptoms, preventing disease progression and enhancing functional capacity. In chronic conditions, where treatment is typically longterm, therapy adherence becomes a key determinant of whether a patient can lead an active, fulfilling life. Non-adherence can result in the worsening of symptoms, increased disability and a diminished quality of life. For example, in patients with asthma or chronic obstructive pulmonary disease (COPD), failing to take inhaled medications as prescribed can lead to frequent exacerbations, decreased lung function and an increased risk of hospitalization. As a result, patients may experience limitations in their daily activities, reduced physical functioning and increased psychological distress, all of which negatively affect their overall quality of life [2].

In contrast, when patients adhere to their prescribed therapies, they are more likely to experience symptom relief, improved physical functioning and better psychological well-being. For instance, in patients with diabetes, proper adherence to medications and lifestyle changes can lead to better blood sugar control, a reduced risk of complications such as diabetic retinopathy and nephropathy and an overall improvement in health-related quality of life. In cancer patients, adherence to chemotherapy regimens or targeted therapies can increase the likelihood of remission, prolong survival and improve quality of life by reducing tumor-related symptoms and side effects. Therefore, improving therapy adherence is a key strategy for enhancing the overall well-being of patients and ensuring that they can achieve the best possible outcomes from their treatment.

The impact of therapy adherence on clinical results is also substantial. Non-adherence to prescribed treatments is one of the primary reasons for suboptimal clinical outcomes in chronic diseases. Patients who do not take their medications as directed may experience disease progression, more frequent exacerbations and a higher risk of complications. This is particularly problematic in conditions that require long-term treatment, such as hypertension, diabetes and heart disease. For example, in patients with hypertension, nonadherence to antihypertensive medications can lead to poorly controlled blood pressure, increasing the risk of cardiovascular events such as heart attacks, strokes and kidney failure. Similarly, in patients with heart failure, failure to adhere to prescribed medications can result in worsening symptoms, frequent hospitalizations and reduced survival [3].

One of the most significant consequences of non-adherence is the increased healthcare costs associated with poor treatment outcomes. Nonadherence often leads to the need for additional medical interventions, including hospitalizations, emergency room visits and the use of more expensive treatments. The economic burden of non-adherence is particularly evident in chronic diseases, where patients may require frequent medical attention and extended hospital stays due to exacerbations or complications resulting from poor disease management. For example, in patients with heart failure, non-adherence to medications can lead to recurrent hospitalizations, which significantly increase healthcare costs. A study published in the American Journal of Managed Care found that non-adherence to heart failure medications was associated with an estimated annual cost of $13 billion in the United States alone, primarily due to hospital admissions and emergency room visits.

Similarly, in diabetes management, non-adherence to medications or lifestyle recommendations can result in the development of complications such as diabetic retinopathy, nephropathy and neuropathy, which require expensive treatments and interventions. A study published in Diabetes Care estimated that non-adherence to diabetes medications resulted in an additional $4 billion in annual healthcare costs in the United States. Moreover, patients who do not adhere to their prescribed treatments may require more intensive and expensive interventions in the long term, further driving up healthcare costs. Therefore, improving therapy adherence is not only beneficial for patient outcomes but also has significant economic implications for healthcare systems, potentially reducing the need for costly hospitalizations and long-term treatments [4,5].

Conclusion

Improving therapy adherence is a critical factor in enhancing patient quality of life, improving clinical outcomes and reducing healthcare costs. Non-adherence to prescribed treatments can lead to disease progression, increased complications and unnecessary healthcare utilization, while good adherence is associated with better health outcomes, reduced morbidity and lower healthcare costs. Addressing the factors that influence adherence, such as patient-related and healthcare system factors, is essential for developing effective strategies to improve adherence. By implementing interventions such as patient education, reminder systems, simplified regimens and adherencemonitoring technologies, healthcare providers can improve therapy adherence and ultimately enhance patient outcomes.

Acknowledgment

None.

Conflict of Interest

None.

References

1. Elnaem, Mohamed Hassan, Nor Afifah Irwan, Usman Abubakar and Syed Azhar Syed Sulaiman, et al. "Impact of medication regimen simplification on medication adherence and clinical outcomes in patients with long-term medical conditions." Patient Prefer Adherence (2020): 2135-2145.

Google Scholar, Crossref, Indexed at

2. Fiorillo andrea, Stefano Barlati, Antonello Bellomo and Giulio Corrivetti, et al. "The role of shared decision-making in improving adherence to pharmacological treatments in patients with schizophrenia: A clinical review." Ann Gen Psychiatry 19 (2020): 1-12.

Google Scholar, Crossref, Indexed at